Abstract:The importance of protein kinase B (AKT) in tumorigenesis and development is well established, but its potential regulation of metabolic reprogramming via phosphorylation of the hexokinase (HK) isozymes remains unclear. There are two HK family members (HK1/2) and three AKT family members (AKT1/2/3), with varied distribution of AKTs exhibiting distinct functions in different tissues and cell types. Although AKT is known to phosphorylate HK2 at threonine 473, AKT‐mediated phosphorylation of HK1 has not been reported. We examined direct binding and phosphorylation of HK1/2 by AKT1 and identified the phosphorylation modification sites using coimmunoprecipitation, glutathione pull‐down, western blotting, and in vitro kinase assays. Regulation of HK activity through phosphorylation by AKT1 was also examined. Uptake of 2‐[1,2‐3H]‐deoxyglucose and production of lactate were investigated to determine whether AKT1 regulates glucose metabolism by phosphorylating HK1/2. Functional assays, immunohistochemistry, and tumor experiments in mice were performed to investigate whether AKT1‐mediated regulation of tumor development is dependent on its kinase activity and/or the involvement of HK1/2. AKT interacted with and phosphorylated HK1 and HK2. Serine phosphorylation significantly increased AKT kinase activity, thereby enhancing glycolysis. Mechanistically, the phosphorylation of HK1 at serine 178 (S178) by AKT significantly decreased the Km and enhanced the Vmax by interfering with the formation of HK1 dimers. Mutations in the AKT phosphorylation sites of HK1 or HK2 significantly abrogated the stimulatory characteristics of AKT on glycolysis, tumorigenesis, and cell migration, invasion, proliferation, and metastasis. HK1‐S178 phosphorylation levels were significantly correlated with the occurrence and metastasis of different types of clinical tumors. We conclude that AKT not only regulates tumor glucose metabolism by directly phosphorylating HK1 and HK2, but also plays important roles in tumor progression, proliferation, and migration.

Akt Methylation by SETDB1 Promotes Akt Kinase Activity and Oncogenic Functions

SETDB1-mediated Methylation of Akt Promotes Its K63-linked Ubiquitination and Activation Leading to Tumorigenesis

Fine-tuning AKT kinase activity through direct lysine methylation.

N<SUP>6</SUP>-methyladenosine mRNA methylation of <i>PIK3CB</i> regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression

S6K1-mediated Phosphorylation of PDK1 Impairs AKT Kinase Activity and Oncogenic Functions

PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis

A Subset of Metastatic Pancreatic Ductal Adenocarcinomas Depends Quantitatively on Oncogenic Kras/Mek/Erk-Induced Hyperactive Mtor Signalling

Data from Akt SUMOylation Regulates Cell Proliferation and Tumorigenesis

Akt/PKB Interacts with the Histone H3 Methyltransferase SETDB1 and Coordinates to Silence Gene Expression

AKT-mediated regulation of chromatin ubiquitylation and tumorigenesis through Mel18 phosphorylation

SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.

PTEN regulation by Akt-EGR1-ARF-PTEN axis.

PRMT5 activates AKT via methylation to promote tumor metastasis

Oncogenic DNA methyltransferase 1 activates the PI3K/AKT/mTOR signalling by blocking the binding of HSPB8 and BAG3 in melanoma

Arginine methylation coordinates with phosphorylation to regulate NADP+ synthesis

MERTK Mediated Novel Site Akt Phosphorylation Alleviates SAV1 Suppression.

AKT1 Promotes Tumorigenesis and Metastasis by Directly Phosphorylating Hexokinases

Phosphatidylinositol 3-kinase/protein kinase B pathway stabilizes DNA methyltransferase I protein and maintains DNA methylation.

Essential Role of AKT-1/Protein Kinase Bα in PTEN-Controlled Tumorigenesis

Data from Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer